JP2015500864A - 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対して免疫するための安定な組成物 - Google Patents

黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対して免疫するための安定な組成物 Download PDF

Info

Publication number
JP2015500864A
JP2015500864A JP2014548063A JP2014548063A JP2015500864A JP 2015500864 A JP2015500864 A JP 2015500864A JP 2014548063 A JP2014548063 A JP 2014548063A JP 2014548063 A JP2014548063 A JP 2014548063A JP 2015500864 A JP2015500864 A JP 2015500864A
Authority
JP
Japan
Prior art keywords
seq
antigen
composition
sta006
esxab
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014548063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500864A5 (cg-RX-API-DMAC10.html
Inventor
マリオ コントルニ，
マリオ コントルニ，
ロレンツォ ターリ，
ロレンツォ ターリ，
アナ コスローヴィ，
アナ コスローヴィ，
ミケーレ ソトジュー，
ミケーレ ソトジュー，
Original Assignee
ノバルティス アーゲー
ノバルティス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アーゲー, ノバルティス アーゲー filed Critical ノバルティス アーゲー
Publication of JP2015500864A publication Critical patent/JP2015500864A/ja
Publication of JP2015500864A5 publication Critical patent/JP2015500864A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2014548063A 2011-12-23 2012-12-21 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対して免疫するための安定な組成物 Pending JP2015500864A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161580191P 2011-12-23 2011-12-23
US61/580,191 2011-12-23
PCT/EP2012/076609 WO2013092985A1 (en) 2011-12-23 2012-12-21 Stable compositions for immunising against staphylococcus aureus

Publications (2)

Publication Number Publication Date
JP2015500864A true JP2015500864A (ja) 2015-01-08
JP2015500864A5 JP2015500864A5 (cg-RX-API-DMAC10.html) 2015-12-10

Family

ID=47520086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548063A Pending JP2015500864A (ja) 2011-12-23 2012-12-21 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対して免疫するための安定な組成物

Country Status (5)

Country Link
US (1) US20150044251A1 (cg-RX-API-DMAC10.html)
EP (1) EP2793939A1 (cg-RX-API-DMAC10.html)
JP (1) JP2015500864A (cg-RX-API-DMAC10.html)
CN (1) CN104023744A (cg-RX-API-DMAC10.html)
WO (1) WO2013092985A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025516318A (ja) * 2022-05-04 2025-05-27 エヴァクシオン・バイオテック・アクティエセルスカブ ブドウ球菌タンパク質変異体およびトランケート

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012214677B2 (en) 2011-02-08 2016-11-10 Abvacc, Inc. Immunogenic composition comprising alpha-hemolysin oligopeptides
WO2013162746A1 (en) * 2012-04-26 2013-10-31 University Of Chicago Staphylococcal coagulase antigens and methods of their use
TR201910573T4 (tr) 2012-08-31 2019-08-21 Glaxosmithkline Biologicals Sa Staphylococcus aureus'a karşı bağışıklık kazandırmak için stabilize edilmiş proteinler.
EP3077820B1 (en) * 2013-12-03 2025-02-26 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
MX377794B (es) 2014-03-26 2025-03-10 Glaxosmithkline Biologicals Sa Antigenos estafilococicos mutantes.
CN104147599B (zh) * 2014-06-24 2017-03-01 华中科技大学 一种疫苗佐剂、其制备方法及应用
WO2016095832A1 (en) * 2014-12-18 2016-06-23 The University Of Hong Kong Immunotherapeutic targets against staphylococcus aureus
US10946084B2 (en) 2016-02-22 2021-03-16 Evaxion Biotech Aps Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
CN113893340B (zh) * 2021-09-30 2024-10-22 中牧实业股份有限公司 双相油佐剂口蹄疫疫苗的稳定剂及其应用
WO2023172741A2 (en) * 2022-03-11 2023-09-14 The Children's Medical Center Corporation A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine comprising b- and t-cell antigens, immunogenic composition, and uses thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525909A (ja) * 2000-03-07 2003-09-02 メルク エンド カムパニー インコーポレーテッド アデノウイルス製剤
JP2005538939A (ja) * 2002-04-11 2005-12-22 メディミューン・ヴァクシンズ・インコーポレーテッド 凍結乾燥フォームによる生物活性材料の保存
JP2006519028A (ja) * 2003-02-25 2006-08-24 メッドイミューン バクシーンズ、インコーポレイティド インフルエンザワクチン組成物を生成する方法
JP2008179636A (ja) * 1994-06-02 2008-08-07 Quadrant Drug Delivery Ltd 各種物質の再水和または融解時の凝集を防止する方法及び該方法により得られる組成物
JP2008266341A (ja) * 2004-05-21 2008-11-06 Novartis Vaccines & Diagnostic Inc 呼吸器系病原体ワクチンのためのアルファウイルスベクター
JP2009508866A (ja) * 2005-09-16 2009-03-05 メリアル リミテッド 凍結乾燥ワクチン用安定剤
WO2010061193A2 (en) * 2008-11-28 2010-06-03 Circassia Limited Compositions with reduced dimer formation
WO2010119343A2 (en) * 2009-04-14 2010-10-21 Novartis Ag Compositions for immunising against staphylococcus aureus
JP2011132234A (ja) * 2003-10-23 2011-07-07 Novartis Vaccines & Diagnostics Inc 安定化組成物
JP2011137047A (ja) * 1999-12-02 2011-07-14 Novartis Vaccines & Diagnostics Inc 凍結乾燥の際に生物学的分子を安定化するための組成物および方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6314729A (ja) * 1986-06-30 1988-01-21 スミスクライン・バイオロジカルス・ソシエテ・アノニム 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン
WO1990014837A1 (en) 1989-05-25 1990-12-13 Chiron Corporation Adjuvant formulation comprising a submicron oil droplet emulsion
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
US6080725A (en) 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
CA2330610A1 (en) 1998-05-07 1999-11-11 Corixa Corporation Adjuvant composition and methods for its use
ES2284287T3 (es) 1998-10-16 2007-11-01 Glaxosmithkline Biologicals S.A. Sistemas adyuvantes y vacunas.
US6355271B1 (en) 1999-02-03 2002-03-12 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
AU5731200A (en) * 1999-06-11 2001-01-02 Endorex Corporation Adjuvant-containing polymerized liposomes for oral, mucosal or intranasal vaccination
KR20110132416A (ko) 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
RS20070078A (sr) * 2004-08-27 2008-11-28 Panacea Biotec Ltd., Inaktivirana vakcina protiv poliomijelitisa nastala iz sabinovog soja polio virusa
US20060228369A1 (en) 2005-04-11 2006-10-12 Program For Appropriate Technology In Health Stabilization and preservation of temperature-sensitive vaccines
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
CN101180081B (zh) * 2005-05-25 2015-08-26 诺沃-诺迪斯克有限公司 稳定的多肽制剂
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
WO2007027076A1 (es) * 2005-09-01 2007-03-08 Nuno Ayala Jose Luis Formula estabilizadora de vacunas con antígenos vivos para su uso en sistemas de vacunación masiva
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
JP2009539979A (ja) 2006-06-12 2009-11-19 ナビ バイオファーマシューティカルズ ブドウ球菌感染症を治療および予防するための、α毒素の使用
CN100460013C (zh) * 2006-09-05 2009-02-11 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法
CA2664619C (en) 2006-10-12 2012-12-11 Glaxosmithkline Biologicals S.A. Immunogenic compositions comprising an oil-in-water emulsion adjuvant containing a reduced amount of squalene, tocol and an emulsifying agent
KR20100072228A (ko) 2007-08-31 2010-06-30 유니버시티 오브 시카고 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
US9950062B2 (en) 2009-09-02 2018-04-24 Glaxosmithkline Biologicals Sa Compounds and compositions as TLR activity modulators
CN102258537B (zh) * 2011-07-15 2012-07-04 骆延波 鸡传染性法氏囊病特异性转移因子的制备方法

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008179636A (ja) * 1994-06-02 2008-08-07 Quadrant Drug Delivery Ltd 各種物質の再水和または融解時の凝集を防止する方法及び該方法により得られる組成物
JP2011137047A (ja) * 1999-12-02 2011-07-14 Novartis Vaccines & Diagnostics Inc 凍結乾燥の際に生物学的分子を安定化するための組成物および方法
JP2003525909A (ja) * 2000-03-07 2003-09-02 メルク エンド カムパニー インコーポレーテッド アデノウイルス製剤
JP2005538939A (ja) * 2002-04-11 2005-12-22 メディミューン・ヴァクシンズ・インコーポレーテッド 凍結乾燥フォームによる生物活性材料の保存
JP2006519028A (ja) * 2003-02-25 2006-08-24 メッドイミューン バクシーンズ、インコーポレイティド インフルエンザワクチン組成物を生成する方法
JP2011132234A (ja) * 2003-10-23 2011-07-07 Novartis Vaccines & Diagnostics Inc 安定化組成物
JP2008266341A (ja) * 2004-05-21 2008-11-06 Novartis Vaccines & Diagnostic Inc 呼吸器系病原体ワクチンのためのアルファウイルスベクター
JP2009508866A (ja) * 2005-09-16 2009-03-05 メリアル リミテッド 凍結乾燥ワクチン用安定剤
WO2010061193A2 (en) * 2008-11-28 2010-06-03 Circassia Limited Compositions with reduced dimer formation
WO2010119343A2 (en) * 2009-04-14 2010-10-21 Novartis Ag Compositions for immunising against staphylococcus aureus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025516318A (ja) * 2022-05-04 2025-05-27 エヴァクシオン・バイオテック・アクティエセルスカブ ブドウ球菌タンパク質変異体およびトランケート

Also Published As

Publication number Publication date
WO2013092985A1 (en) 2013-06-27
CN104023744A (zh) 2014-09-03
EP2793939A1 (en) 2014-10-29
US20150044251A1 (en) 2015-02-12

Similar Documents

Publication Publication Date Title
US9926344B2 (en) Stabilised proteins for immunising against Staphylococcus aureus
US20150044251A1 (en) Stable compositions for immunising against staphylococcus aureus
JP2020007351A (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓに対して免疫化するための組成物
US10328140B2 (en) Mutant staphylococcal antigens
US20150202277A1 (en) Stabilised proteins for immunising against staphylococcus aureus
ES2826555T3 (es) Antígenos de Pseudomonas y combinación de antígenos
US20150203543A1 (en) Stabilised proteins for immunising against staphylococcus aureus
CA3020313A1 (en) Novel pneumococcal vaccine formulations
CA2888829A1 (en) Staphylococcal immunogens
US20150191513A1 (en) Stabilised proteins for immunising against staphylococcus aureus

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151019

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151019

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160628

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170303